mSphere (Apr 2021)

CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge

  • Yan Yan,
  • Kai Hu,
  • Ming Fu,
  • Xu Deng,
  • Sukun Luo,
  • Lina Tong,
  • Xinmeng Guan,
  • Siyi He,
  • Chang Li,
  • Wei Jin,
  • Tao Du,
  • Zifeng Zheng,
  • Mudan Zhang,
  • Yalan Liu,
  • Qinxue Hu

DOI
https://doi.org/10.1128/mSphere.00058-21
Journal volume & issue
Vol. 6, no. 2

Abstract

Read online

An effective HSV-2 vaccine should induce antigen (Ag)-specific immune responses against viral mucosal infection. This study reveals that chemokine CCL19 or CCL28 enhanced HSV-2 glycoprotein D ectodomain (gD-306aa)-induced immune responses against vaginal virus challenge.